Compare BHST & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BHST | LNSR |
|---|---|---|
| Founded | 2007 | 2004 |
| Country | Canada | United States |
| Employees | 89 | N/A |
| Industry | | Medical Electronics |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.2M | 69.1M |
| IPO Year | N/A | 2005 |
| Metric | BHST | LNSR |
|---|---|---|
| Price | $1.92 | $5.60 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $10.00 | $10.00 |
| AVG Volume (30 Days) | 40.8K | ★ 90.2K |
| Earning Date | 05-15-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $58,435,000.00 |
| Revenue This Year | $146.27 | $10.06 |
| Revenue Next Year | N/A | $41.48 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 9.24 |
| 52 Week Low | $2.00 | $5.06 |
| 52 Week High | $12.80 | $13.32 |
| Indicator | BHST | LNSR |
|---|---|---|
| Relative Strength Index (RSI) | 14.51 | 45.01 |
| Support Level | N/A | $5.58 |
| Resistance Level | $3.47 | $6.20 |
| Average True Range (ATR) | 0.20 | 0.21 |
| MACD | -0.07 | -0.02 |
| Stochastic Oscillator | 0.40 | 27.91 |
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. The Company has two operating segments or business units: the Products business unit and the CDMO Services business unit. In identifying these operating segments, management generally follows the Company's service lines representing its main products and services. The Products Business Unit - Nutraceuticals: Research, development, manufacturing, marketing and sales of science-based health and wellness nutraceutical solutions which are manufactured and sold as dietary supplements, functional food and beverages. The CDMO Services Business Unit - comprising a Contract Development and Manufacturing Operation that offers pharmaceuticals, cosmeceuticals, nutraceuticals, and nutritions.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia (excluding South Korea), South Korea, and Other.